Transplanting lymphoma cells with or without Nr4a1-loss into immune-competent mice led to accelerated lymphoma-development and a decreased survival in the absence of Nr4a1 and to no differences in immune-incompetent mice, indicating that the loss of Nr4a1 results in a suppression of anti-lymphoma immune response. This evidence concerns the gene NR4A1 and lymphoma.